United States - English - NLM (National Library of Medicine)

novo nordisk - insulin aspart (unii: d933668qvx) (insulin aspart - unii:d933668qvx) - insulin aspart 100 [iu] in 1 ml - novolog is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. novolog is contraindicated: risk summary available information from published randomized controlled trials with insulin aspart use during the second trimester of pregnancy have not reported an association with insulin aspart and major birth defects or adverse maternal or fetal outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . in animal reproduction studies, administration of subcutaneous insulin aspart to pregnant rats and rabbits during the period of organogenesis did not cause adverse developmental effects at exposures 8-times and equal to the human subcutaneous dose of 1 unit/kg/day, respectively. pre- and post-implantation losses and visceral/skeletal abnormalities were seen at higher exposures, which are considered secondary to maternal hypoglycemia. these effects were similar to those observed in rats

United States - English - NLM (National Library of Medicine)

novo nordisk - insulin aspart (unii: d933668qvx) (insulin aspart - unii:d933668qvx) - insulin aspart 100 [iu] in 1 ml - fiasp is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. fiasp is contraindicated: risk summary there are no available data with fiasp in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. available information from published randomized controlled trials with insulin aspart use during the second trimester of pregnancy have not reported an association with insulin aspart and major birth defects or adverse maternal or fetal outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . in animal reproduction studies, administration of subcutaneous insulin aspart to pregnant rats and rabbits during the period of organogenesis did not cause adverse developmental effects at exposures 8- times and equal to the human subcutaneous dose of 1.0 unit/kg/day, respectively. pre- and post-implantation losses and visceral/skeletal abnormalities were seen a

United States - English - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - asparagus (unii: z1ejp3037z) (asparagus - unii:z1ejp3037z) - rheumatic pains condition listed above or as directed by the physician

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - asparaginase (unii: g4fq3cky5r) (asparaginase - unii:g4fq3cky5r) -

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - asparaginase (unii: g4fq3cky5r) (asparaginase - unii:g4fq3cky5r) -

United States - English - NLM (National Library of Medicine)

sajjala bio labs private limited - asparaginase (unii: g4fq3cky5r) (asparaginase - unii:g4fq3cky5r) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - asparaginase (unii: g4fq3cky5r) (asparaginase - unii:g4fq3cky5r) -

United States - English - NLM (National Library of Medicine)

changzhou qianhong bio-pharma co., ltd - asparaginase (unii: g4fq3cky5r) (asparaginase - unii:g4fq3cky5r) -

Bangladesh - English - DGDA (Directorate General of Drug Administration)

deeplaid pharmaco ltd. (homoeo) - asparagus officinalis - liquid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - asparaginase - powder for solution for injection - 5000unit